Suresh S. Ramalingam
Suresh S. Ramalingam publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.
- World rank
- #17,691 of 7,710,434 ranked researchers
- Rank in United States
- #6,344 of 1,627,098
- Works
- 1,235
- Citations
- 101k
- Citations per work
- 81.5
What does Suresh S. Ramalingam research?
Suresh S. Ramalingam's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences75260.9%
- Medicine75260.9%
- Life Sciences25720.8%
- Everything else22618.3%
- 1Pulmonary and Respiratory Medicine30% of their works
- 2Oncology29% of their works
- 3Molecular Biology13% of their works
- 4Cancer Research5% of their works
- 5Radiology, Nuclear Medicine and Imaging2% of their works
- 6Immunology2% of their works
Research topics
Which keywords describe Suresh S. Ramalingam's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles, Small-Cell Lung Cancer and CT Screening.
- Signaling
- DNA
- Cetuximab
- Cancer Genomics
- Immune Checkpoint Blockade
- CT Screening
- Genomic Profiles
- ALK Inhibitors
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- EGFR Mutations
- Small-Cell Lung Cancer
- Lung Cancer
- PD-1 and PD-L1
- Mutational Signatures
- KRAS Mutations
- Topoisomerases
- mTOR
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Targeted Therapy8253 topics
- Clinical Trials7142 topics
- Chemotherapy5754 topics
- ALK Inhibitors4791 topic
- EGFR Mutations4791 topic
- Genomic Profiles2351 topic
- Small-Cell Lung Cancer2351 topic
- CT Screening1861 topic
- Lung Cancer1861 topic
- Immune Checkpoint Blockade1831 topic
- PD-1 and PD-L11831 topic
- Cancer Genomics1111 topic
- Mutational Signatures1111 topic
- Cetuximab971 topic
- KRAS Mutations971 topic
- DNA571 topic
- Topoisomerases571 topic
- Signaling421 topic
- mTOR421 topic
Where does Suresh S. Ramalingam work?
Suresh S. Ramalingam's main affiliation in the publication record is Emory University, United States.
How many publications and citations does Suresh S. Ramalingam have?
OpenAlex counts 1,235 works and 100,647 citations for Suresh S. Ramalingam, an h-index of 126, ranking #17,691 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Suresh S. Ramalingam. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.